Global Report Life Sciences

Benign Prostatic Hyperplasia Treatment Market—Global Forecast 2026

consainsights.com
Benign Prostatic Hyperplasia Treatment Market by Type, End-user, Region, Trends, Competitive Analysis, and Growth Opportunities, Key Insights.

Overview

Benign Prostatic Hyperplasia Treatment Market from Consainsights analyses the Benign Prostatic Hyperplasia Treatment Market in the Life Sciences industry over the forecast period to 2026.

Benign Prostatic Hyperplasia Treatment research report from Consainsights outlines the detailed strategic analysis, trends, market opportunities, growth prospects, industry and market challenges and sustainable solutions to sustain in the competitive environment.

Benign Prostatic Hyperplasia Treatment segmentation includes Type, End-user and Geography.

Market analysis on the basis of Type include Drug Treatment, Surgical Treatment. This segmentation encompasses the key innovations and micro & macro trends, companies/manufacturers operating in this space along with their usage and penetration with respect to the wide range of End Users. Additionally, market sizing information along with the key factors such as market drivers, restraints, opportunities and challenges which are likely to be influencing the market growth are outlined in this report.

Based on the End-user, the Benign Prostatic Hyperplasia Treatment Market analysis covers Home Healthcare, Hospitals & Clinics.

Key companies operating in the market include and so on. This report covers the detailed analysis of the company profiles such as business segments, product portfolio, key brand insights and growth strategies adopted, company SWOT and Strategy analysis along with the financial analysis and analyst insights on the key companies operating in this market.

Moreover, the competitive analysis includes the companies deals such as Mergers, Acquisitions, Partnerships and so on along with the expansion areas focusing on the additional geographies, future insights for success and market share analysis. Major players strategies include the launch of the innovative product lines along with the emphasis on the partnerships and acquisitions to standardize their market share in the market space.

Market Research methodology includes the triangulation of the data from the data sources such as Primary Market Research approach and Secondary Market Research Approach along with the data from the trade bodies and industry standard publications and data sources. Primary inputs from the industry experts and the market respondents from the respective industries to obtain very critical information to assess the future growth prospects of the market. The final data is triangulated and thoroughly validated considering all the data sources using the bottom-up and the top-down approaches to estimate the market sizing of the individual segments.

The Benign Prostatic Hyperplasia Treatment Market is segmented into the following categories:

Benign Prostatic Hyperplasia Treatment Market by Type:

  • Drug Treatment
  • Surgical Treatment

Benign Prostatic Hyperplasia Treatment Market by End-user:

  • Home Healthcare
  • Hospitals & Clinics

Table of Contents

  1. Executive Summary

  2. Benign Prostatic Hyperplasia Treatment Market Overview

    1. Benign Prostatic Hyperplasia Treatment Market Definition & Scope
    2. Currency, Year and Forecasts Overview
    3. Benign Prostatic Hyperplasia Treatment Market 360° Synopsis: Overview
  3. Benign Prostatic Hyperplasia Treatment Industry Analysis

    1. Industry Value Chain Analysis
    2. Key Companies at each phase of Value Chain
    3. Industry Trend Analysis
  4. Benign Prostatic Hyperplasia Treatment Market Analysis

    1. Drives, Restraints, Opportunities and Challenges Impact Analysis
    2. Porter’s Five Force Model Analysis
    3. PESTLE Analysis
    4. BPS Analysis
    5. Benign Prostatic Hyperplasia Treatment Market Key Innovation & Trends
    6. Pricing Patterns (Company & Product Type)
  5. Benign Prostatic Hyperplasia Treatment Market: Type

    1. Introduction
    2. Drug Treatment: Market Trends, Size, and Forecast (2017-2026)

      1. Alpha Blockers
      2. 5-Alpha Reductase Inhibitors
      3. Other Drug Classes
    3. Surgical Treatment: Market Trends, Size, and Forecast (2017-2026)

      1. Transurethral Resection of the Prostate
      2. Laser Surgery
      3. Transurethral Microwave Thermotherapy
      4. Urolift Therapy
      5. Transurethral Needle Ablation of the Prostate
      6. Rezūm Therapy
      7. Prostatic Stenting
      8. Other Surgeries
  6. Benign Prostatic Hyperplasia Treatment Market: End-user

    1. Introduction
    2. Home Healthcare: Market Trends, Size, and Forecast (2017-2026)
    3. Hospitals & Clinics: Market Trends, Size, and Forecast (2017-2026)
  7. Global Analysis

    1. Global Benign Prostatic Hyperplasia Treatment Market, By Region, Y-O-Y Growth Analysis

      1. Introduction
      2. North America: Market Trends, Size, and Forecast (2017-2026)
      3. Europe: Market Trends, Size, and Forecast (2017-2026)
      4. Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)
      5. Latin America: Market Trends, Size, and Forecast (2017-2026)
      6. Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)
  8. North America Analysis

    1. North America Benign Prostatic Hyperplasia Treatment Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. United States: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United States Benign Prostatic Hyperplasia Treatment Market: Type
        3. United States Benign Prostatic Hyperplasia Treatment Market: End-user
      3. Canada: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Canada Benign Prostatic Hyperplasia Treatment Market: Type
        3. Canada Benign Prostatic Hyperplasia Treatment Market: End-user
    2. North America Benign Prostatic Hyperplasia Treatment Market, By Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Drug Treatment: Market Trends, Size, and Forecast (2017-2026)

        1. Alpha Blockers
        2. 5-Alpha Reductase Inhibitors
        3. Other Drug Classes
      3. Surgical Treatment: Market Trends, Size, and Forecast (2017-2026)

        1. Transurethral Resection of the Prostate
        2. Laser Surgery
        3. Transurethral Microwave Thermotherapy
        4. Urolift Therapy
        5. Transurethral Needle Ablation of the Prostate
        6. Rezūm Therapy
        7. Prostatic Stenting
        8. Other Surgeries
    3. North America Benign Prostatic Hyperplasia Treatment Market, By End-user, Y-O-Y Growth Analysis

      1. Introduction
      2. Home Healthcare: Market Trends, Size, and Forecast (2017-2026)
      3. Hospitals & Clinics: Market Trends, Size, and Forecast (2017-2026)
  9. Europe Analysis

    1. Europe Benign Prostatic Hyperplasia Treatment Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Germany: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Germany Benign Prostatic Hyperplasia Treatment Market: Type
        3. Germany Benign Prostatic Hyperplasia Treatment Market: End-user
      3. United Kingdom: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. United Kingdom Benign Prostatic Hyperplasia Treatment Market: Type
        3. United Kingdom Benign Prostatic Hyperplasia Treatment Market: End-user
      4. France: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. France Benign Prostatic Hyperplasia Treatment Market: Type
        3. France Benign Prostatic Hyperplasia Treatment Market: End-user
      5. Spain: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Spain Benign Prostatic Hyperplasia Treatment Market: Type
        3. Spain Benign Prostatic Hyperplasia Treatment Market: End-user
      6. Russia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Russia Benign Prostatic Hyperplasia Treatment Market: Type
        3. Russia Benign Prostatic Hyperplasia Treatment Market: End-user
      7. Italy: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Italy Benign Prostatic Hyperplasia Treatment Market: Type
        3. Italy Benign Prostatic Hyperplasia Treatment Market: End-user
      8. Rest of Europe: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Europe Benign Prostatic Hyperplasia Treatment Market: Type
        3. Rest of Europe Benign Prostatic Hyperplasia Treatment Market: End-user
    2. Europe Benign Prostatic Hyperplasia Treatment Market, By Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Drug Treatment: Market Trends, Size, and Forecast (2017-2026)

        1. Alpha Blockers
        2. 5-Alpha Reductase Inhibitors
        3. Other Drug Classes
      3. Surgical Treatment: Market Trends, Size, and Forecast (2017-2026)

        1. Transurethral Resection of the Prostate
        2. Laser Surgery
        3. Transurethral Microwave Thermotherapy
        4. Urolift Therapy
        5. Transurethral Needle Ablation of the Prostate
        6. Rezūm Therapy
        7. Prostatic Stenting
        8. Other Surgeries
    3. Europe Benign Prostatic Hyperplasia Treatment Market, By End-user, Y-O-Y Growth Analysis

      1. Introduction
      2. Home Healthcare: Market Trends, Size, and Forecast (2017-2026)
      3. Hospitals & Clinics: Market Trends, Size, and Forecast (2017-2026)
  10. Asia-Pacific Analysis

    1. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. China: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. China Benign Prostatic Hyperplasia Treatment Market: Type
        3. China Benign Prostatic Hyperplasia Treatment Market: End-user
      3. Japan: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Japan Benign Prostatic Hyperplasia Treatment Market: Type
        3. Japan Benign Prostatic Hyperplasia Treatment Market: End-user
      4. India: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. India Benign Prostatic Hyperplasia Treatment Market: Type
        3. India Benign Prostatic Hyperplasia Treatment Market: End-user
      5. Southeast Asia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Southeast Asia Benign Prostatic Hyperplasia Treatment Market: Type
        3. Southeast Asia Benign Prostatic Hyperplasia Treatment Market: End-user
      6. Australia & New Zealand: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Australia & New Zealand Benign Prostatic Hyperplasia Treatment Market: Type
        3. Australia & New Zealand Benign Prostatic Hyperplasia Treatment Market: End-user
      7. Rest of Asia-Pacific: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Asia-Pacific Benign Prostatic Hyperplasia Treatment Market: Type
        3. Rest of Asia-Pacific Benign Prostatic Hyperplasia Treatment Market: End-user
    2. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, By Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Drug Treatment: Market Trends, Size, and Forecast (2017-2026)

        1. Alpha Blockers
        2. 5-Alpha Reductase Inhibitors
        3. Other Drug Classes
      3. Surgical Treatment: Market Trends, Size, and Forecast (2017-2026)

        1. Transurethral Resection of the Prostate
        2. Laser Surgery
        3. Transurethral Microwave Thermotherapy
        4. Urolift Therapy
        5. Transurethral Needle Ablation of the Prostate
        6. Rezūm Therapy
        7. Prostatic Stenting
        8. Other Surgeries
    3. Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, By End-user, Y-O-Y Growth Analysis

      1. Introduction
      2. Home Healthcare: Market Trends, Size, and Forecast (2017-2026)
      3. Hospitals & Clinics: Market Trends, Size, and Forecast (2017-2026)
  11. Latin America Analysis

    1. Latin America Benign Prostatic Hyperplasia Treatment Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Brazil: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Brazil Benign Prostatic Hyperplasia Treatment Market: Type
        3. Brazil Benign Prostatic Hyperplasia Treatment Market: End-user
      3. Argentina: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Argentina Benign Prostatic Hyperplasia Treatment Market: Type
        3. Argentina Benign Prostatic Hyperplasia Treatment Market: End-user
      4. Mexico: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Mexico Benign Prostatic Hyperplasia Treatment Market: Type
        3. Mexico Benign Prostatic Hyperplasia Treatment Market: End-user
      5. Colombia: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Colombia Benign Prostatic Hyperplasia Treatment Market: Type
        3. Colombia Benign Prostatic Hyperplasia Treatment Market: End-user
      6. Rest of Latin America: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Latin America Benign Prostatic Hyperplasia Treatment Market: Type
        3. Rest of Latin America Benign Prostatic Hyperplasia Treatment Market: End-user
    2. Latin America Benign Prostatic Hyperplasia Treatment Market, By Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Drug Treatment: Market Trends, Size, and Forecast (2017-2026)

        1. Alpha Blockers
        2. 5-Alpha Reductase Inhibitors
        3. Other Drug Classes
      3. Surgical Treatment: Market Trends, Size, and Forecast (2017-2026)

        1. Transurethral Resection of the Prostate
        2. Laser Surgery
        3. Transurethral Microwave Thermotherapy
        4. Urolift Therapy
        5. Transurethral Needle Ablation of the Prostate
        6. Rezūm Therapy
        7. Prostatic Stenting
        8. Other Surgeries
    3. Latin America Benign Prostatic Hyperplasia Treatment Market, By End-user, Y-O-Y Growth Analysis

      1. Introduction
      2. Home Healthcare: Market Trends, Size, and Forecast (2017-2026)
      3. Hospitals & Clinics: Market Trends, Size, and Forecast (2017-2026)
  12. Middle East & Africa Analysis

    1. Middle East & Africa Benign Prostatic Hyperplasia Treatment Market, By Country, Y-O-Y Growth Analysis

      1. Introduction
      2. Middle East: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Middle East Benign Prostatic Hyperplasia Treatment Market: Type
        3. Middle East Benign Prostatic Hyperplasia Treatment Market: End-user
      3. Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Africa Benign Prostatic Hyperplasia Treatment Market: Type
        3. Africa Benign Prostatic Hyperplasia Treatment Market: End-user
      4. Rest of Middle East & Africa: Market Trends, Size, and Forecast (2017-2026)

        1. Introduction
        2. Rest of Middle East & Africa Benign Prostatic Hyperplasia Treatment Market: Type
        3. Rest of Middle East & Africa Benign Prostatic Hyperplasia Treatment Market: End-user
    2. Middle East & Africa Benign Prostatic Hyperplasia Treatment Market, By Type, Y-O-Y Growth Analysis

      1. Introduction
      2. Drug Treatment: Market Trends, Size, and Forecast (2017-2026)

        1. Alpha Blockers
        2. 5-Alpha Reductase Inhibitors
        3. Other Drug Classes
      3. Surgical Treatment: Market Trends, Size, and Forecast (2017-2026)

        1. Transurethral Resection of the Prostate
        2. Laser Surgery
        3. Transurethral Microwave Thermotherapy
        4. Urolift Therapy
        5. Transurethral Needle Ablation of the Prostate
        6. Rezūm Therapy
        7. Prostatic Stenting
        8. Other Surgeries
    3. Middle East & Africa Benign Prostatic Hyperplasia Treatment Market, By End-user, Y-O-Y Growth Analysis

      1. Introduction
      2. Home Healthcare: Market Trends, Size, and Forecast (2017-2026)
      3. Hospitals & Clinics: Market Trends, Size, and Forecast (2017-2026)
  13. Benign Prostatic Hyperplasia Treatment Market: Company Analysis

    1. Introduction
  14. Benign Prostatic Hyperplasia Treatment Market: Competitive Analysis

    1. Strategic Dashboard of Top Market Players
    2. Companies Deals (Mergers, Partnerships, Acquisitions, JVs)
    3. Expansion Areas (Based on Company Analysis)
    4. Market Share Analysis
  15. Benign Prostatic Hyperplasia Treatment Market: Distribution Channel Analysis

    1. Distributor Type Analysis
    2. Major Distributors (Key Countries)
    3. Future Growth Prospects
  16. Industry & Analysts Insights for Success

  17. Research Methodology

  18. Appendix

    1. List of Tables
    2. List of Figures
    3. Available Customizations
    4. Related Reports

List of Figures

Figure 1: Global Benign Prostatic Hyperplasia Treatment Market: Structure

Figure 2: Global Benign Prostatic Hyperplasia Treatment Market: Value Chain Analysis

Figure 3: Global Benign Prostatic Hyperplasia Treatment Market: Porter's Five Forces Model

Figure 4: Global Benign Prostatic Hyperplasia Treatment Market: Market Dynamics

Figure 5: Global Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Figure 6: Global Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Figure 7: Global Benign Prostatic Hyperplasia Treatment Market, By Region, 2016-2026 (USD Million)

Figure 8: North America Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Figure 9: North America Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Figure 10: North America Benign Prostatic Hyperplasia Treatment Market, By Country, 2016-2026 (USD Million)

Figure 11: Europe Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Figure 12: Europe Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Figure 13: Europe Benign Prostatic Hyperplasia Treatment Market, By Country, 2016-2026 (USD Million)

Figure 14: Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Figure 15: Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Figure 16: Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, By Country, 2016-2026 (USD Million)

Figure 17: Latin America Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Figure 18: Latin America Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Figure 19: Latin America Benign Prostatic Hyperplasia Treatment Market, By Country, 2016-2026 (USD Million)

Figure 20: Middle East & Africa Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Figure 21: Middle East & Africa Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Figure 22: Middle East & Africa Benign Prostatic Hyperplasia Treatment Market, By Country, 2016-2026 (USD Million)

List of Tables

Table 1: Global Benign Prostatic Hyperplasia Treatment Market, By Type, 2017-2026 (USD Million)

Table 2: Global Benign Prostatic Hyperplasia Treatment Market, By End-user, 2017-2026 (USD Million)

Table 3: Global Benign Prostatic Hyperplasia Treatment Market, By Region, 2017-2026 (USD Million)

Table 4: North America Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 5: North America Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 6: North America Benign Prostatic Hyperplasia Treatment Market, By Country, 2016-2026 (USD Million)

Table 7: United States Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 8: United States Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 9: Canada Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 10: Canada Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 11: Europe Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 12: Europe Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 13: Europe Benign Prostatic Hyperplasia Treatment Market, By Country, 2016-2026 (USD Million)

Table 14: Germany Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 15: Germany Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 16: United Kingdom Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 17: United Kingdom Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 18: France Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 19: France Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 20: Spain Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 21: Spain Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 22: Russia Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 23: Russia Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 24: Italy Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 25: Italy Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 26: Rest of Europe Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 27: Rest of Europe Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 28: Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 29: Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 30: Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, By Country, 2016-2026 (USD Million)

Table 31: China Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 32: China Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 33: Japan Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 34: Japan Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 35: India Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 36: India Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 37: Southeast Asia Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 38: Southeast Asia Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 39: Australia & New Zealand Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 40: Australia & New Zealand Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 41: Rest of Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 42: Rest of Asia-Pacific Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 43: Latin America Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 44: Latin America Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 45: Latin America Benign Prostatic Hyperplasia Treatment Market, By Country, 2016-2026 (USD Million)

Table 46: Brazil Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 47: Brazil Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 48: Argentina Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 49: Argentina Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 50: Mexico Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 51: Mexico Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 52: Colombia Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 53: Colombia Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 54: Rest of Latin America Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 55: Rest of Latin America Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 56: Middle East & Africa Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 57: Middle East & Africa Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 58: Middle East & Africa Benign Prostatic Hyperplasia Treatment Market, By Country, 2016-2026 (USD Million)

Table 59: Middle East Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 60: Middle East Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 61: Africa Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 62: Africa Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)

Table 63: Rest of Middle East & Africa Benign Prostatic Hyperplasia Treatment Market, By Type, 2016-2026 (USD Million)

Table 64: Rest of Middle East & Africa Benign Prostatic Hyperplasia Treatment Market, By End-user, 2016-2026 (USD Million)